June 16, 2011

In Thailand, conducted clinical trials of the world's first vaccine against severe disease - Dengue . Already the first interim results obtained from the use of the vaccine developed by the well-known company that produces drugs Sanofi-Aventis .

As the subjects were selected by about four thousand children, the youngest four years old, the eldest of eleven years. The challenges faced by scientists to determine the degree of drug safety, the identification of adverse reactions and complications after vaccination. Experimental studies, which began in 2009 should last for four years.

Vaccination of children is carried out in several stages. The interval between administration of the drug is six months. So far, according to the head of research Professor Aruni Sabsharona from Mahidol University, Bangkok, any serious consequences and complications of the drug were found.

Thailand is not the only country where clinical trials of the vaccine, just an experiment involving 15 countries, vaccination test formulations should provide protection from strains That causes dengue fever. Every year hundreds of thousands of people worldwide fall ill the infection, and the frequent deaths.